Search Results 831-840 of 17432 for chlamydiachlamydia
Departments that treat this condition · Colon and Rectal Surgery · Gastroenterology and Hepatology · Inflammatory Bowel Disease Clinic · Laboratory Medicine and ...
This study is designed to evaluate PFS endpoint for acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia. Participation eligibility.
This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Syphilis · Tension headache · Tongue cancer · Transposition of the great arteries · Triple X syndrome · Type 1 diabetes in children · Ureteral cancer · Vaginal ...
One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...
The purpose of this study is to test the hypothesis that patients with PKD have abnormal endothelial function and increased oxidative stress from early stages ( ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20132102.
Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.